Plantar Fasciitis Treatment Market Size, Share & Trends Analysis Report By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids), By Disease Type, By End Use, By Region, And Segment Forecasts, 2025 - 2033
The global plantar fasciitis treatment market size was estimated at USD 1.28 billion in 2024 and is projected to reach USD 3.45 billion by 2033, growing at a CAGR of 11.9% from 2025 to 2033. The market growth is driven by rising prevalence of obesity, an aging population, and an increase in heel and foot strain cases caused by prolonged standing or high-impact activities.
Increasing awareness among patients about foot health, better access to specialized care, and the adoption of advanced treatment options are further supporting market expansion. Hospitals, clinics, and outpatient facilities are emphasizing early diagnosis and effective management of foot-related conditions. Combined, these factors are fueling demand for therapeutic interventions, driving consistent growth and encouraging innovation within the heel and foot care segment.
Although governments rarely provide exact global case figures, estimates suggest that approximately 1 million patient visits yearly are due to plantar fasciitis. Research indicates that around 10% of the population experience plantar fasciitis at some point, with 83% of affected individuals being active working adults aged 25 to 65. Some studies report prevalence rates as high as 22% among runners.
Developments in image-guided interventions, ultrasound-guided injections, and minimally invasive mechanical or sonic therapies improve targeting, reduce recovery time, and enhance efficacy, thus increasing physician and patient adoption. In July 2025, a study published in the American Journal of Physical Medicine & Rehabilitation compared the efficacy of platelet-rich plasma (PRP) and corticosteroids in treating plantar fasciitis. The results indicated that PRP provided superior pain relief and improved foot function over corticosteroid injections. In addition, in July 2025, a study by King George's Medical University researchers in Lucknow explored the effectiveness of ultrasound-guided dextrose prolotherapy versus PRP injections for chronic heel pain. The study found that both treatments significantly reduced pain and improved foot function, with PRP demonstrating slightly superior outcomes.
Global Plantar Fasciitis Treatment Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global plantar fasciitis treatment market report based on drug class, disease type, end use, and region:
Increasing awareness among patients about foot health, better access to specialized care, and the adoption of advanced treatment options are further supporting market expansion. Hospitals, clinics, and outpatient facilities are emphasizing early diagnosis and effective management of foot-related conditions. Combined, these factors are fueling demand for therapeutic interventions, driving consistent growth and encouraging innovation within the heel and foot care segment.
Although governments rarely provide exact global case figures, estimates suggest that approximately 1 million patient visits yearly are due to plantar fasciitis. Research indicates that around 10% of the population experience plantar fasciitis at some point, with 83% of affected individuals being active working adults aged 25 to 65. Some studies report prevalence rates as high as 22% among runners.
Developments in image-guided interventions, ultrasound-guided injections, and minimally invasive mechanical or sonic therapies improve targeting, reduce recovery time, and enhance efficacy, thus increasing physician and patient adoption. In July 2025, a study published in the American Journal of Physical Medicine & Rehabilitation compared the efficacy of platelet-rich plasma (PRP) and corticosteroids in treating plantar fasciitis. The results indicated that PRP provided superior pain relief and improved foot function over corticosteroid injections. In addition, in July 2025, a study by King George's Medical University researchers in Lucknow explored the effectiveness of ultrasound-guided dextrose prolotherapy versus PRP injections for chronic heel pain. The study found that both treatments significantly reduced pain and improved foot function, with PRP demonstrating slightly superior outcomes.
Global Plantar Fasciitis Treatment Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global plantar fasciitis treatment market report based on drug class, disease type, end use, and region:
- Drug Class Outlook (Revenue, USD Billion, 2021 - 2033)
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Corticosteroids
- Others
- Disease Type Outlook (Revenue, USD Billion, 2021 - 2033)
- Acute Plantar Fasciitis
- Chronic Plantar Fasciitis
- Others
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Class
1.2.2. Disease Type
1.2.3. End Use
1.2.4. Region
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. PLANTAR FASCIITIS TREATMENT MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. PLANTAR FASCIITIS TREATMENT MARKET: DRUG CLASS BUSINESS ANALYSIS
4.1. Drug Class Market Share, 2024 & 2033
4.2. Drug Class Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Billion)
4.4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
4.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
4.5. Corticosteroids
4.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
4.6. Others
4.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
CHAPTER 5. PLANTAR FASCIITIS TREATMENT MARKET: DISEASE TYPE BUSINESS ANALYSIS
5.1. Disease Type Market Share, 2024 & 2033
5.2. Disease Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Disease Type, 2021 to 2033 (USD Billion)
5.4. Acute Plantar Fasciitis
5.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
5.5. Chronic Plantar Fasciitis
5.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
5.6. Others
5.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
CHAPTER 6. PLANTAR FASCIITIS TREATMENT MARKET: END USE BUSINESS ANALYSIS
6.1. End Use Market Share, 2024 & 2033
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
6.4. Hospitals & Clinics
6.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
6.5. Ambulatory Surgical Centers
6.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
6.6. Others
6.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
CHAPTER 7. PLANTAR FASCIITIS TREATMENT MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
7.4. North America
7.4.1. North America Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Framework
7.4.2.5. U.S. Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Framework
7.4.3.5. Canada Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Framework
7.4.4.5. Mexico Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5. Europe
7.5.1. Europe Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Framework
7.5.2.5. UK Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Framework
7.5.3.5. Germany Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement Framework
7.5.4.5. France Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Regulatory Framework
7.5.5.4. Reimbursement Framework
7.5.5.5. Italy Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Regulatory Framework
7.5.6.4. Reimbursement Framework
7.5.6.5. Spain Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement Framework
7.5.7.5. Denmark Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Target Disease Prevalence
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement Framework
7.5.8.5. Sweden Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Target Disease Prevalence
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement Framework
7.5.9.5. Norway Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6. Asia Pacific
7.6.1. Asia Pacific Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Framework
7.6.2.5. Japan Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Framework
7.6.3.5. China Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Framework
7.6.4.5. India Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Framework
7.6.5.5. Australia Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement Framework
7.6.6.5. South Korea Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Target Disease Prevalence
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement Framework
7.6.7.5. Thailand Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.7. Latin America
7.7.1. Latin America Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement Framework
7.7.2.5. Brazil Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement Framework
7.7.3.5. Argentina Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Target Disease Prevalence
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement Framework
7.8.2.5. South Africa Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Target Disease Prevalence
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement Framework
7.8.3.5. Saudi Arabia Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Target Disease Prevalence
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement Framework
7.8.4.5. UAE Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Target Disease Prevalence
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement Framework
7.8.5.5. Kuwait Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Pfizer Inc.
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Bayer AG
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Johnson & Johnson
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Viatris Inc.
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Teva Pharmaceutical Industries Ltd.
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Sanofi
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. AbbVie Inc.
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. GSK plc.
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Novartis AG
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Sun Pharmaceutical Industries Ltd.
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Class
1.2.2. Disease Type
1.2.3. End Use
1.2.4. Region
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. PLANTAR FASCIITIS TREATMENT MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. PLANTAR FASCIITIS TREATMENT MARKET: DRUG CLASS BUSINESS ANALYSIS
4.1. Drug Class Market Share, 2024 & 2033
4.2. Drug Class Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Billion)
4.4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
4.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
4.5. Corticosteroids
4.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
4.6. Others
4.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
CHAPTER 5. PLANTAR FASCIITIS TREATMENT MARKET: DISEASE TYPE BUSINESS ANALYSIS
5.1. Disease Type Market Share, 2024 & 2033
5.2. Disease Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Disease Type, 2021 to 2033 (USD Billion)
5.4. Acute Plantar Fasciitis
5.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
5.5. Chronic Plantar Fasciitis
5.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
5.6. Others
5.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
CHAPTER 6. PLANTAR FASCIITIS TREATMENT MARKET: END USE BUSINESS ANALYSIS
6.1. End Use Market Share, 2024 & 2033
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
6.4. Hospitals & Clinics
6.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
6.5. Ambulatory Surgical Centers
6.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
6.6. Others
6.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
CHAPTER 7. PLANTAR FASCIITIS TREATMENT MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
7.4. North America
7.4.1. North America Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Framework
7.4.2.5. U.S. Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Framework
7.4.3.5. Canada Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Framework
7.4.4.5. Mexico Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5. Europe
7.5.1. Europe Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Framework
7.5.2.5. UK Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Framework
7.5.3.5. Germany Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement Framework
7.5.4.5. France Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Regulatory Framework
7.5.5.4. Reimbursement Framework
7.5.5.5. Italy Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Regulatory Framework
7.5.6.4. Reimbursement Framework
7.5.6.5. Spain Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement Framework
7.5.7.5. Denmark Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Target Disease Prevalence
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement Framework
7.5.8.5. Sweden Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Target Disease Prevalence
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement Framework
7.5.9.5. Norway Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6. Asia Pacific
7.6.1. Asia Pacific Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Framework
7.6.2.5. Japan Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Framework
7.6.3.5. China Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Framework
7.6.4.5. India Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Framework
7.6.5.5. Australia Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement Framework
7.6.6.5. South Korea Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Target Disease Prevalence
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement Framework
7.6.7.5. Thailand Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.7. Latin America
7.7.1. Latin America Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement Framework
7.7.2.5. Brazil Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement Framework
7.7.3.5. Argentina Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Plantar Fasciitis Treatment Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Target Disease Prevalence
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement Framework
7.8.2.5. South Africa Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Target Disease Prevalence
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement Framework
7.8.3.5. Saudi Arabia Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Target Disease Prevalence
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement Framework
7.8.4.5. UAE Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Target Disease Prevalence
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement Framework
7.8.5.5. Kuwait Plantar Fasciitis Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Pfizer Inc.
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Bayer AG
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Johnson & Johnson
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Viatris Inc.
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Teva Pharmaceutical Industries Ltd.
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Sanofi
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. AbbVie Inc.
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. GSK plc.
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Novartis AG
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Sun Pharmaceutical Industries Ltd.
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global plantar fasciitis treatment market, by region, 2021 - 2033 (USD Billion)
Table 4 Global plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 5 Global plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 6 Global plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 7 North America plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
Table 8 North America plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 9 North America plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 10 North America plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 11 US plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 12 US plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 13 US plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 14 Canada plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 15 Canada plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 16 Canada plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 17 Mexico plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 18 Mexico plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 19 Mexico plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 20 Europe plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
Table 21 Europe plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 22 Europe plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 23 Europe plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 24 UK plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 25 UK plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 26 UK plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 27 Germany plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 28 Germany plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 29 Germany plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 30 France plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 31 France plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 32 France plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 33 Italy plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 34 Italy plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 35 Italy plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 36 Spain plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 37 Spain plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 38 Spain plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 39 Denmark plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 40 Denmark plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 41 Denmark plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 42 Sweden plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 43 Sweden plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 44 Sweden plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 45 Norway plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 46 Norway plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 47 Norway plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 48 Asia Pacific plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
Table 49 Asia Pacific plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 50 Asia Pacific plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 51 Asia Pacific plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 52 Japan plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 53 Japan plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 54 Japan plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 55 China plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 56 China plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 57 China plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 58 India plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 59 India plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 60 India plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 61 Australia plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 62 Australia plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 63 Australia plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 64 South Korea plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 65 South Korea plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 66 South Korea plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 67 Thailand plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 68 Thailand plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 69 Thailand plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 70 Latin America plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
Table 71 Latin America plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 72 Latin America plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 73 Latin America plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 74 Brazil plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 75 Brazil plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 76 Brazil plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 77 Argentina plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 78 Argentina plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 79 Argentina plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 80 Middle East & Africa plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
Table 81 Middle East & Africa plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 82 Middle East & Africa plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 83 Middle East & Africa plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 84 South Africa plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 85 South Africa plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 86 South Africa plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 87 Saudi Arabia plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 88 Saudi Arabia plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 89 Saudi Arabia plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 90 UAE plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 91 UAE plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 92 UAE plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 93 Kuwait plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 94 Kuwait plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 95 Kuwait plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global plantar fasciitis treatment market, by region, 2021 - 2033 (USD Billion)
Table 4 Global plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 5 Global plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 6 Global plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 7 North America plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
Table 8 North America plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 9 North America plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 10 North America plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 11 US plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 12 US plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 13 US plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 14 Canada plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 15 Canada plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 16 Canada plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 17 Mexico plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 18 Mexico plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 19 Mexico plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 20 Europe plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
Table 21 Europe plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 22 Europe plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 23 Europe plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 24 UK plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 25 UK plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 26 UK plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 27 Germany plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 28 Germany plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 29 Germany plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 30 France plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 31 France plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 32 France plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 33 Italy plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 34 Italy plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 35 Italy plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 36 Spain plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 37 Spain plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 38 Spain plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 39 Denmark plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 40 Denmark plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 41 Denmark plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 42 Sweden plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 43 Sweden plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 44 Sweden plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 45 Norway plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 46 Norway plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 47 Norway plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 48 Asia Pacific plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
Table 49 Asia Pacific plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 50 Asia Pacific plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 51 Asia Pacific plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 52 Japan plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 53 Japan plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 54 Japan plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 55 China plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 56 China plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 57 China plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 58 India plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 59 India plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 60 India plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 61 Australia plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 62 Australia plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 63 Australia plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 64 South Korea plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 65 South Korea plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 66 South Korea plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 67 Thailand plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 68 Thailand plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 69 Thailand plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 70 Latin America plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
Table 71 Latin America plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 72 Latin America plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 73 Latin America plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 74 Brazil plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 75 Brazil plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 76 Brazil plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 77 Argentina plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 78 Argentina plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 79 Argentina plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 80 Middle East & Africa plantar fasciitis treatment market, by country, 2021 - 2033 (USD Billion)
Table 81 Middle East & Africa plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 82 Middle East & Africa plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 83 Middle East & Africa plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 84 South Africa plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 85 South Africa plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 86 South Africa plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 87 Saudi Arabia plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 88 Saudi Arabia plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 89 Saudi Arabia plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 90 UAE plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 91 UAE plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 92 UAE plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
Table 93 Kuwait plantar fasciitis treatment market, by drug class, 2021 - 2033 (USD Billion)
Table 94 Kuwait plantar fasciitis treatment market, by disease type, 2021 - 2033 (USD Billion)
Table 95 Kuwait plantar fasciitis treatment market, by end use, 2021 - 2033 (USD Billion)
LIST OF FIGURES
Fig. 1 Plantar fasciitis treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and disease outlook (USD Billion)
Fig. 10 Competitive landscape
Fig. 11 Plantar fasciitis treatment market dynamics
Fig. 12 Plantar fasciitis treatment market: Porter’s five forces analysis
Fig. 13 Plantar fasciitis treatment market: PESTLE analysis
Fig. 14 Plantar fasciitis treatment market: Drug class movement analysis
Fig. 15 Plantar fasciitis treatment market: Drug class outlook and key takeaways
Fig. 16 Nonsteroidal anti-inflammatory drugs (NSAIDs) market estimates and forecast, 2021 - 2033
Fig. 17 Corticosteroids market estimates and forecast, 2021 - 2033
Fig. 18 Others market estimates and forecast, 2021 - 2033
Fig. 19 Plantar fasciitis treatment market: Disease type movement analysis
Fig. 20 Plantar fasciitis treatment market: Disease type outlook and key takeaways
Fig. 21 Acute plantar fasciitis market estimates and forecast, 2021 - 2033
Fig. 22 Chronic plantar fasciitis market estimates and forecast, 2021 - 2033
Fig. 23 Others market estimates and forecast, 2021 - 2033
Fig. 24 Plantar fasciitis treatment market: End use movement analysis
Fig. 25 Plantar fasciitis treatment market: End use outlook and key takeaways
Fig. 26 Hospitals & clinics market estimates and forecast, 2021 - 2033
Fig. 27 Ambulatory surgical centers market estimates and forecast, 2021 - 2033
Fig. 28 Others market estimates and forecast, 2021 - 2033
Fig. 29 Plantar fasciitis treatment market: Regional movement analysis
Fig. 30 Plantar fasciitis treatment market: Regional outlook and key takeaways
Fig. 31 North America market estimates and forecast, 2021 - 2033
Fig. 32 U.S. market estimates and forecast, 2021 - 2033
Fig. 33 Canada market estimates and forecast, 2021 - 2033
Fig. 34 Mexico market estimates and forecast, 2021 - 2033
Fig. 35 Europe market estimates and forecast, 2021 - 2033
Fig. 36 UK market estimates and forecast, 2021 - 2033
Fig. 37 Germany market estimates and forecast, 2021 - 2033
Fig. 38 France market estimates and forecast, 2021 - 2033
Fig. 39 Italy market estimates and forecast, 2021 - 2033
Fig. 40 Spain market estimates and forecast, 2021 - 2033
Fig. 41 Denmark market estimates and forecast, 2021 - 2033
Fig. 42 Sweden market estimates and forecast, 2021 - 2033
Fig. 43 Norway market estimates and forecast, 2021 - 2033
Fig. 44 Asia Pacific market estimates and forecast, 2021 - 2033
Fig. 45 Japan market estimates and forecast, 2021 - 2033
Fig. 46 China market estimates and forecast, 2021 - 2033
Fig. 47 India market estimates and forecast, 2021 - 2033
Fig. 48 Australia market estimates and forecast, 2021 - 2033
Fig. 49 South Korea market estimates and forecast, 2021 - 2033
Fig. 50 Thailand market estimates and forecast, 2021 - 2033
Fig. 51 Latin America market estimates and forecast, 2021 - 2033
Fig. 52 Brazil market estimates and forecast, 2021 - 2033
Fig. 53 Argentina market estimates and forecast, 2021 - 2033
Fig. 54 Middle East & Africa market estimates and forecast, 2021 - 2033
Fig. 55 South Africa market estimates and forecast, 2021 - 2033
Fig. 56 Saudi Arabia market estimates and forecast, 2021 - 2033
Fig. 57 UAE market estimates and forecast, 2021 - 2033
Fig. 58 Kuwait market estimates and forecast, 2021 - 2033
Fig. 59 Company categorization
Fig. 60 Company market position analysis
Fig. 61 Strategic framework
Fig. 1 Plantar fasciitis treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and disease outlook (USD Billion)
Fig. 10 Competitive landscape
Fig. 11 Plantar fasciitis treatment market dynamics
Fig. 12 Plantar fasciitis treatment market: Porter’s five forces analysis
Fig. 13 Plantar fasciitis treatment market: PESTLE analysis
Fig. 14 Plantar fasciitis treatment market: Drug class movement analysis
Fig. 15 Plantar fasciitis treatment market: Drug class outlook and key takeaways
Fig. 16 Nonsteroidal anti-inflammatory drugs (NSAIDs) market estimates and forecast, 2021 - 2033
Fig. 17 Corticosteroids market estimates and forecast, 2021 - 2033
Fig. 18 Others market estimates and forecast, 2021 - 2033
Fig. 19 Plantar fasciitis treatment market: Disease type movement analysis
Fig. 20 Plantar fasciitis treatment market: Disease type outlook and key takeaways
Fig. 21 Acute plantar fasciitis market estimates and forecast, 2021 - 2033
Fig. 22 Chronic plantar fasciitis market estimates and forecast, 2021 - 2033
Fig. 23 Others market estimates and forecast, 2021 - 2033
Fig. 24 Plantar fasciitis treatment market: End use movement analysis
Fig. 25 Plantar fasciitis treatment market: End use outlook and key takeaways
Fig. 26 Hospitals & clinics market estimates and forecast, 2021 - 2033
Fig. 27 Ambulatory surgical centers market estimates and forecast, 2021 - 2033
Fig. 28 Others market estimates and forecast, 2021 - 2033
Fig. 29 Plantar fasciitis treatment market: Regional movement analysis
Fig. 30 Plantar fasciitis treatment market: Regional outlook and key takeaways
Fig. 31 North America market estimates and forecast, 2021 - 2033
Fig. 32 U.S. market estimates and forecast, 2021 - 2033
Fig. 33 Canada market estimates and forecast, 2021 - 2033
Fig. 34 Mexico market estimates and forecast, 2021 - 2033
Fig. 35 Europe market estimates and forecast, 2021 - 2033
Fig. 36 UK market estimates and forecast, 2021 - 2033
Fig. 37 Germany market estimates and forecast, 2021 - 2033
Fig. 38 France market estimates and forecast, 2021 - 2033
Fig. 39 Italy market estimates and forecast, 2021 - 2033
Fig. 40 Spain market estimates and forecast, 2021 - 2033
Fig. 41 Denmark market estimates and forecast, 2021 - 2033
Fig. 42 Sweden market estimates and forecast, 2021 - 2033
Fig. 43 Norway market estimates and forecast, 2021 - 2033
Fig. 44 Asia Pacific market estimates and forecast, 2021 - 2033
Fig. 45 Japan market estimates and forecast, 2021 - 2033
Fig. 46 China market estimates and forecast, 2021 - 2033
Fig. 47 India market estimates and forecast, 2021 - 2033
Fig. 48 Australia market estimates and forecast, 2021 - 2033
Fig. 49 South Korea market estimates and forecast, 2021 - 2033
Fig. 50 Thailand market estimates and forecast, 2021 - 2033
Fig. 51 Latin America market estimates and forecast, 2021 - 2033
Fig. 52 Brazil market estimates and forecast, 2021 - 2033
Fig. 53 Argentina market estimates and forecast, 2021 - 2033
Fig. 54 Middle East & Africa market estimates and forecast, 2021 - 2033
Fig. 55 South Africa market estimates and forecast, 2021 - 2033
Fig. 56 Saudi Arabia market estimates and forecast, 2021 - 2033
Fig. 57 UAE market estimates and forecast, 2021 - 2033
Fig. 58 Kuwait market estimates and forecast, 2021 - 2033
Fig. 59 Company categorization
Fig. 60 Company market position analysis
Fig. 61 Strategic framework
